Our study highlights a critical intersection between the metabolic reprogramming by adipocytes and the proteolytic regulation of EIF3H‐YAP, offering insights into their combined impact on the progression and therapy resistance of TNBC in the context of obesity. This evidence concerns the gene YAP1 and obesity disorder.